Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
OPS Retail calls shareholder meeting

OPS Retail calls shareholder meeting

ReutersReuters2026/08/10 17:20
  • OPS Retail will hold an ordinary shareholders’ meeting in Assago on Sept. 30, 2026.
  • Shareholders will vote on the size of the board, its term, director appointments, the chair nomination, board pay.
  • The meeting will also appoint the statutory auditors for 2026-2028, name the chair of the statutory auditors, set their compensation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OPS Retail S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 0489-53-2026_TELEBORSA.pdf), on August 10, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.